New Digital Therapeutics Expo Debuts At 2026 OPEN MINDS Service Excellence Institute in San Francisco, California
GETTYSBURG, PA. (January 3, 2026)—OPEN MINDS The first-ever OPEN MINDS Digital Therapeutics Expo will debut this summer as a premier showcase for digital care innovation, bringing health care executives face to face with market-ready digital therapeutics that are reimagining behavioral health and chronic disease treatment. Designed exclusively for executive decision-makers, the Expo will take place during The 2026 OPEN MINDS Service Excellence Institute, August 11–13, 2026, in San Francisco, California.
The Digital Therapeutics Expo offers selected organizations a rare opportunity to demonstrate their solutions in real time to an audience of CEOs, COOs, and clinical leaders actively evaluating technology-enabled care. Through live, 30-minute demonstrations, participating organizations will illustrate how digital therapeutics are redefining care models by integrating clinical rigor with scalable technology. Presentations will focus on how these solutions enhance patient engagement, support measurable outcomes, and enable organizations to modernize and scale treatment strategies in an increasingly digital care environment.
Only eight organizations will be selected nationwide to participate in this highly curated event. Eligible applicants include organizations offering FDA-cleared or authorized digital therapeutics, diagnostics, or treatment solutions designed for behavioral health or chronic disease management. The limited format ensures meaningful engagement, peer visibility, and focused executive attention throughout the Expo.
Lisa Palko, Executive Director of the Society of Digital Mental Health & OPEN MINDS Advisory Board Member, along with Paul Duck, Chief Strategy Officer at OPEN MINDS, will chair the Expo together. They bring deep expertise in digital mental health, strategy, and health care innovation, shaping a program aligned with the real-world needs of provider and payer organizations navigating digital adoption.
Participation in the Expo enables presenting organizations to position themselves as thought leaders in digital health, gain direct feedback from senior executives on product positioning and storytelling, and engage multiple prospective buyers in a single, high-impact forum, helping to accelerate decision-making and shorten sales cycles.
Applications to present must be submitted by February 25, 2026.
For additional information about presenting or attending, or if you’re interested in sponsoring The 2026 OPEN MINDS Digital Therapeutics Expo, please contact edeppen@openminds.com.
Attendance to the Expo is included with registration for The 2026 OPEN MINDS Service Excellence Institute, which brings together executive leaders focused on operational excellence, innovation, and technology adoption across health and human services.
Registration is now open. Registration is included for OPEN MINDS Circle Market Intelligence Service subscribers. Non-members can register at excellence.openminds.com.
For questions about OPEN MINDS’ educational programs, sponsorship opportunities, or media inquiries, contact the Executive Education Events team at events@openminds.com or 717-334-1329.
This program is made possible by the OPEN MINDS premier partners, Alera Health, ContinuumCloud, Core Solutions, Netsmart, Otsuka, and Qualifacts.
About OPEN MINDS
OPEN MINDS is a national market intelligence, management consulting, and marketing services firm specializing exclusively in the high-needs consumer market – mental health, addiction treatment, cognitive disabilities, chronic health conditions, elder services, health-related social needs, and adjacent markets within the health and human service field. The OPEN MINDS mission is to provide payers, service provider organizations, pharmaceutical, technology, and scientific firms that serve these consumers with the market and management knowledge needed to improve their organizational efficiency and effectiveness. Learn more at openminds.com.